A piece of evidence in support of this antisteatotic function was the in vivo demonstration in leptin-unresponsive fa/fa ZDF rats exhibiting transgenic overexpression of the wild-type leptin receptor in their livers prevented the severe hepatic steatosis and hypertriglyceridemia that otherwise occurred [72]. Here, LEP is linked to fatty liver disease.